MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 558548 | Name: Centalun

Description:

WARNING: This product is for research use only, not for human or veterinary use.

The composite material of corundum ceramic containing vancomycin is of high compatibility and could be regarded as the good drug carrier.

Chemical Structure

Centalun
CAS#2033-94-5

Theoretical Analysis

MedKoo Cat#: 558548

Name: Centalun

CAS#: 2033-94-5

Chemical Formula: C11H12O2

Exact Mass: 176.0800

Molecular Weight: 176.21

Elemental Analysis: C, 74.98; H, 6.86; O, 18.16

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Centalun; KO 339; KOE 339;
IUPAC/Chemical Name
3-Butyne-1,2-diol, 2-methyl-1-phenyl-
InChi Key
GQOXDWHRXDPZJK-UHFFFAOYSA-N
InChi Code
InChI=1S/C11H12O2/c1-3-11(2,13)10(12)9-7-5-4-6-8-9/h1,4-8,10,12-13H,2H3
SMILES Code
C#CC(O)(C)C(C1=CC=CC=C1)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 176.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: GERLACH W, GERLACH E. [EXPERIENCES WITH CENTALUN IN OBSTETRICAL AND GYNECOLOGICAL PATIENTS]. Med Monatsschr. 1964 Mar;18:131-3. German. PubMed PMID: 14193290. 2: KOCH L. [Clinical experiences with Centalun, a new hypnoticsedative preparation]. Munch Med Wochenschr. 1963 Jun 14;105:1273-5. German. PubMed PMID: 14034019. 3: MONECKE K. [PRE- AND POSTOPERATIVE USE OF CENTALUN IN SURGERY]. Dtsch Med J. 1964 Jul 5;15:470-1. German. PubMed PMID: 14238754. 4: LUEBBERS VP. [ALLERGIC THROMBOCYTOPENIC PURPURA FOLLOWING CENTALUN INTAKE]. Dtsch Med Wochenschr. 1964 Aug 21;89:1596-7. German. PubMed PMID: 14171184. 5: VON KOBYLETZKI, SCHMIDT G. [CLINICAL EXPERIENCES FOLLOWING ADMINISTRATION OF CENTALUN IN THE PUERPERIUM]. Med Welt. 1964 Aug 1;31:1655-61. German. PubMed PMID: 14291137. 6: BRUCKSCHEN E. [SEDATIVE THERAPY WITH CENTALUN IN ORTHOPEDICS]. Dtsch Med J. 1964 Jul 20;15:493-4. German. PubMed PMID: 14243120. 7: MESSERICH J. [Our experiences with the sedative and hypnotic Centalun in cardiovascular diseases]. Ther Ggw. 1963 May;102:579-83. German. PubMed PMID: 13935131. 8: ERNST W. [ON THE SYMPTOMATIC USE OF THE HYPNOTIC AND SEDATIVE CENTALUN IN INTERNAL DISEASES]. Hippokrates. 1964 Jan 15;35:31-2. German. PubMed PMID: 14167584. 9: Schmidt W. [An additional case of thrombocytopenia due to Centalun]. Dtsch Med Wochenschr. 1968 Jun;93(23):1152. German. PubMed PMID: 5648361. 10: SMOLENSKI O. [ON THE TREATMENT OF SLEEP DISORDERS. REPORT ON TESTS WITH CENTALUN]. Med Welt. 1964 Feb 29;40:435-6. German. PubMed PMID: 14152700. 11: SCHANZ G. [On the use of the sedative and tranquilizing agent Centalun. Therapeutic results in a women's hospital]. Med Monatsschr. 1963 May;17:309-10. German. PubMed PMID: 13976686. 12: WILDE KM. [ON THE USE OF CENTALUN IN SLEEP THERAPY]. Med Welt. 1963 Oct 19;42:2144-5. German. PubMed PMID: 14093056. 13: FRIEDERICHS P. [My experiences with the sedative Centalun in a nursing home and home for the aged]. Med Monatsschr. 1963 May;17:310-1. German. PubMed PMID: 13959763. 14: Schreiber H. [A reagent for the demonstration of Centalun]. Arch Toxikol. 1965;21(2):128-30. German. PubMed PMID: 5866836. 15: Lübbers P. [Thrombocytopenic purpura following administration of centalun]. Dtsch Med Wochenschr. 1966 Dec 23;91(51):2299-300. German. PubMed PMID: 5951712. 16: Mikolajek A. [Polarographic determination of centalun in the blood]. Przegl Lek. 1966;22(9):612-4. Polish. PubMed PMID: 5925397. 17: Burger E. [Investigations on the identification of a new barbiturate-free hypnotic composed of 3-methyl-3, 4-dihydroxy-4-phenylbutin-1 ("Centalun") in toxicological analysis]. Arch Toxikol. 1965;21(2):121-7. German. PubMed PMID: 5866835. 18: JANKE W, GLATHE H. [EXPERIMENTAL STUDIES ON THE PSYCHIC EFFECT OF SEDATIVES UNDER NORMAL AND STRESS CONDITIONS]. Psychol Forsch. 1964 Jun 2;27:377-402. German. PubMed PMID: 14233519. 19: WAGNER W. [CETALUN IN DERMATOLOGY]. Z Haut Geschlechtskr. 1964 Jun 1;36:353-5. German. PubMed PMID: 14234437.